GlucoTrack, Inc. (GCTK)
$1.03-7.21%Close
SELLCRISIS · day 46
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $584,480
- Beta
- 0.68
- P/E (TTM)
- -0.01
- Short % float
- 21.60%
- Days to cover
- 1.0
- SI change
- +26.4%
- 1W
- -14.88%
- 1M
- -68.11%
- vs SPY 1W
- -16.04%
- vs SPY 1M
- -71.10%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on GCTK?
- LOPJLB’s latest quantitative signal on GlucoTrack, Inc. (GCTK) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is GCTK in?
- GlucoTrack, Inc. (GCTK) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does GlucoTrack, Inc. (GCTK) do?
- GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.